-
Investigating the Mechanism of Jiawei Weijin Decoction in Treating Non-Small Cell Lung Cancer Using Network Pharmacology, Bioinformatics Analysis and Experimental Validation
25 Sep 2025 08:23 GMT
… small cell lung cancer (NSCLC) cases among all lung cancer cases … , the prevalent treatments of lung cancer mainly include surgery, radiotherapy … kg, i.g. daily), cisplatin (CDDP, n=12, i … #47;mTOR pathway in lung cancer; oncogenic alterations, therapeutic …
-
New Cancer Drug Could Finally Overcome Resistance to Lung Cancer Treatments
24 Sep 2025 19:03 GMT
… lung cancer (NSCLC)—which accounts for 80-85% of all lung cancer … recurrence and metastasis of lung cancer, eliminating them could … Similarly, chemotherapy drugs like cisplatin, though widely used, have … were effective even in lung cancer cells that had …
-
Peritoneal Metastasis in Non-Small Cell Lung Cancer: A Systematic Review of Clinical Features, Molecular Profiles, Diagnostic Approaches, and Outcomes
19 Sep 2025 09:19 GMT
… CBDCA, Carboplatin; CDDP, Cisplatin; CK7, Cytokeratin 7; CK20 … secondary to metastatic lung cancer complicated with acute … small cell lung cancer independent of oncogene status. Lung Cancer. 2016 … small cell lung cancer by functional class. Lung Cancer. 2019; …
-
Dermatotoxicity of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: Current Advances in Mechanistic Insights and Predictive Biomarker Identification
17 Sep 2025 09:09 GMT
… cells are enriched in lung tumors and inflammatory lung … -small cell lung cancer treated with nivolumab. Lung Cancer. 2019;132 … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2021;10 … or in combination with cisplatin plus gemcitabine in Japanese …
-
Osimertinib Plus Chemo Significantly Extends Survival for Patients With Lung Cancer
16 Sep 2025 16:39 GMT
… of smoking, but EGFRm lung cancers present more in atypical populations … with other types of lung cancers, the immune systems in … mg/m2) plus either cisplatin (75 mg/m2) … html
2. Lung Cancer Foundation of America. EGFR. Lung Cancer Foundation of America …
-
FLAURA2 phase III trial of AstraZeneca's Tagrisso plus chemotherapy demonstrated a median overall survival in EGFR─mutated advanced lung cancer
09 Sep 2025 10:38 GMT
… (EGFRm) non-small cell lung cancer (NSCLC).
These results presented … deaths. Lung cancer is broadly split into small cell lung cancer or … (500mg/m2) plus cisplatin (75mg/m2) or … improvements for people with lung cancer, including and beyond treatment …
-
Cisplatin/Carboplatin Plus Etoposide Yield Similar Real-World Efficacy in ES-SCLC
17 Sep 2025 01:13 GMT
… with 30% of the cisplatin and etoposide group receiving … study confirms that either [cisplatin and etoposide] or [carboplatin … of carboplatin-etoposide vs cisplatin-etoposide in ES-SCLC. … the Study of Lung Cancer World Conference on Lung Cancer 2025; September …
-
AstraZeneca Lung Cancer Combo Extends Patient Survival By Years In Key Study
08 Sep 2025 18:12 GMT
… (Stage IV) non-small cell lung cancer (NSCLC) whose tumors have EGFR … the addition of chemotherapy plus cisplatin or carboplatin every three weeks …
-
HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025
05 Sep 2025 00:00 GMT
… 2025 World Conference on Lung Cancer (“WCLC”) taking place … in non-small cell lung cancer (“NSCLC”) patients will … 22
Poster: Small Cell Lung Cancer and Neuroendocrine Tumors
Tuesday, … Combined with Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab …
-
Engineering Study on Targeted Therapy of Osteosarcoma Using Tripterine Loaded Polydopamine Mesoporous Microspheres Combined with Photothermal Therapy
24 Sep 2025 09:50 GMT
… methotrexate (MTX), doxorubicin (ADR), and cisplatin (DDP) are employed to mitigate … glioma, leukemia, melanoma, pancreatic cancer, lung cancer, prostate cancer, breast cancer, and …
About
© 1995-2025